RBMX2 links Mycobacterium bovis infection to epithelial–mesenchymal transition and lung cancer progression
eLife · 24.11.2025 · 14
DOI: 10.7554/elife.107132 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 24.11.2025. Verfasst von Chao Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: The National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, RNA-Binding Proteins, Lung Neoplasms, Mycobacterium bovis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major projects of agricultural biological breeding, National Natural Science Foundation of China, China Agriculture Research System of MOF and MARA.
Abstract (Originalsprache)
Tuberculosis (TB) is a complex disease caused by the interaction of pathogen, host, and environmental factors. In 2022, TB affected 10.6 million people and caused 1.3 million deaths globally. In high-burden zoonotic TB regions, Mycobacterium bovis accounts for ~10% of human TB cases. The immune evasion and latency of Mycobacterium tuberculosis hinder understanding of host responses. Here, we identify RNA-binding motif protein X-linked 2 (RBMX2) as a novel host factor facilitating M. bovis infection. RBMX2 expression is significantly upregulated in multiple cell types, including EBL, BoMac, bovine alveolar primary cells, and human A549 cells. Multi-omics analyses, cell adhesion assays, and ChIP-PCR demonstrate that RBMX2 suppresses cell adhesion and tight junctions while enhancing M. bovis adhesion and invasion via p65 signaling. Integrated transcriptomic, proteomic, and metabolomic data reveal that RBMX2 regulates epithelial–mesenchymal transition (EMT), a process linked to cancer progression. TIMER2.0 analysis shows elevated RBMX2 expression in lung adenocarcinoma and lung squamous cell carcinoma tissues, validated by immunofluorescence. Using an M. bovis -induced BoMac-EBL EMT model and H1299 cells, we show that RBMX2 promotes EMT through p65/MMP-9 pathway activation. Collectively, RBMX2 is a novel host factor that enhances M. bovis infection and drives infection-induced EMT. These findings provide new insight into TB pathogenesis and highlight RBMX2 as a potential target for TB vaccine and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
- National Animal Tuberculosis Para-Reference Laboratory (Wuhan) of Ministry of Agriculture and Rural Affairs, Huazhong Agricultural University, Wuhan, China.
- Center for Infectious Disease Research, School of Medicine, Westlake University, Hangzhou, China.
- Oncology Collaborative Innovation Center, Inner Mongolia Medical University, Hohhot, China.
- Department of Cell Biology, Inner Mongolia Medical University, Hohhot, China.
- Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, United States.
ORCID-Profile: Lei Zhang, Yingyu Chen
Förderung
- Major projects of agricultural biological breeding
- National Natural Science Foundation of China
- China Agriculture Research System of MOF and MARA
- Inner Mongolia Medical University
Zitieren
APA
Wang, C., Peng, Y., Yang, H., Jiang, Y., Khalid, A. K., Zhang, K., Xie, S., Bermudez, L., Yang, Y., Zhang, L., Chen, H., Guo, A., & Chen, Y. (2025). RBMX2 links Mycobacterium bovis infection to epithelial–mesenchymal transition and lung cancer progression. eLife, 14. https://doi.org/10.7554/elife.107132
Vancouver
Wang C, Peng Y, Yang H, Jiang Y, Khalid AK, Zhang K, et al. RBMX2 links Mycobacterium bovis infection to epithelial–mesenchymal transition and lung cancer progression. eLife. 2025;14. doi:10.7554/elife.107132
BibTeX
@article{Wang2025,
author = {Wang, Chao and Peng, Yongchong and Yang, Hongxin and Jiang, Yanzhu and Khalid, Abdul Karim and Zhang, Kailun and Xie, Shengsong and Bermudez, Luiz and Yang, Yong and Zhang, Lei and Chen, Huanchun and Guo, Aizhen and Chen, Yingyu},
title = {RBMX2 links Mycobacterium bovis infection to epithelial–mesenchymal transition and lung cancer progression},
journal = {eLife},
year = {2025},
volume = {14},
doi = {10.7554/elife.107132}
}
EUVIMED